Article

Researcher receives funding support from Research to Prevent Blindness

Philip Ruzycki, PhD, receives a career development award that will provide $350,000 to support his laboratory over the next 4 years.

Philip Ruzycki, PhD, an assistant professor in the John F. Hardesty, MD, Department of Ophthalmology and Visual Sciences, at Washington University School of Medicine in St. Louis, has received a career development award from Research to Prevent Blindness.

Philip Ruzycki, PhD

Philip Ruzycki, PhD

The award provides $350,000 to support Ruzycki’s laboratory over the next 4 years

The award is given to support the independent pursuits of promising basic scientists and clinician-scientists who are early in their careers and who study the visual system. Ruzycki’s research applies molecular genetics techniques, along with computational biology, to analyze the genomic, proteomic and transcriptomic aspects that drive retinal development and disease.

Ruzycki is a graduate of the Molecular Genetics and Genomics program in Washington University’s Division of Biology & Biomedical Sciences (DBBS). He serves as a co-director of the ophthalmology department’s Biostatistics & Bioinformatics Core.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.